How the brain environment influences immune cells after transplantation
Programming of Resident Macrophages by the Brain Environment Following Transplantation
This study is looking at how special immune cells in the brain, called microglia, change after being transplanted, which could help us find new ways to treat brain diseases and improve therapies for patients like you.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10790219 on NIH RePORTER |
What this research studies
This research investigates how microglia, the brain's resident immune cells, adapt to changes in their environment following transplantation. By isolating and transplanting these cells into the brain, researchers will observe how they change over time and identify the genetic and environmental factors that influence their behavior. The study employs advanced techniques like single-cell RNA sequencing to create a detailed profile of these changes, which could lead to new insights into brain diseases and potential therapies. Patients may benefit from a better understanding of how immune responses in the brain can be manipulated for therapeutic purposes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with brain diseases or disorders that may be influenced by immune cell behavior.
Not a fit: Patients with stable brain conditions that do not involve immune response alterations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic targets for treating brain diseases by understanding how immune cells in the brain can be programmed.
How similar studies have performed: Other research has shown promise in understanding immune cell behavior in the brain, but this specific approach is relatively novel.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Bennett, Frederick — University of Pennsylvania
- Study coordinator: Bennett, Frederick
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.